Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
A Boehringer Ingelheim é um parceiro e promotor de produção sustentável de carne de porco e proteína animal, assegurando o bem-estar animal através da prevenção e cuidados de saúde integrados.
Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans.
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs.
Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse.
Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases
Cerca de 425 milhões de pessoas adultas no mundo vivem com diabetes, com a diabetes Tipo 2 a representar 90 - 95% de todos os casos. Prevê-se que este número aumente para 629 milhões de pessoas até 2045.
Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here.